Improved Detection of Rare HIV-1 Variants using 454 Pyrosequencing

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Larsen, Brendan B ^a   Chen, Lennie ^a   Maust, Brandon S ^a   Kim, Moon ^a   Zhao, Hong ^a   Deng, Wenjie ^a   Westfall, Dylan ^a   Beck, Ingrid ^b,c   Frenkel, Lisa M ^a,b,c   Mullins, James I ^a,c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANTAGE2 ENZYME; DNA POLYMERASE; ENZYME; GAG PROTEIN; KAPA HIFI HOT START ENZYME; KOD HS ENZYME; PHUSION ENZYME; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN;

AMPLICON; ARTICLE; ENV GP120 GENE; GAG POL GENE; GENE AMPLIFICATION; GENE SEQUENCE; GENETIC CODE; GENETIC VARIABILITY; GENOMICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; LIMIT OF DETECTION; NONHUMAN; POLYMERASE CHAIN REACTION; PYROSEQUENCING; RNA EXTRACTION; SENSITIVITY ANALYSIS; VIRUS DETECTION; VIRUS GENE;

GENOME, VIRAL; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HIV INFECTIONS; HIV-1; HUMANS; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 84884847857     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076502     Document Type: Article

References (47)

1. Fischer W, Ganusov VV, Giorgi EE, Hraber PT, Keele BF, et al. (2010) Transmission of single HIV-1 genomes and dynamics of early immune escape revealed by ultra-deep sequencing. PLOS ONE 5: e12303. doi:10.1371/journal.pone.0012303. PubMed: 20808830.
2. Henn MR, Boutwell CL, Charlebois P, Lennon NJ, Power KA, et al. (2012) Whole genome deep sequencing of HIV-1 reveals the impact of early minor variants upon immune recognition during acute infection. PLOS Pathog 8: e1002529. PubMed: 22412369.
3. Buzón MJ, Codoñer FM, Frost SD, Pou C, Puertas MC, et al. (2011) Deep molecular characterization of HIV-1 dynamics under suppressive HAART. PLOS Pathog 7: e1002314. PubMed: 22046128.
4. Hedskog C, Mild M, Jernberg J, Sherwood E, Bratt G, et al. (2010) Dynamics of HIV-1 quasispecies during antiviral treatment dissected using ultra-deep pyrosequencing. PLOS ONE 5: e11345. doi:10.1371/journal.pone.0011345. PubMed: 20628644.
5. Lataillade M, Chiarella J, Yang R, DeGrosky M, Uy J, et al. (2012) Virologic failures on initial boosted-PI regimen infrequently possess low-level variants with major PI resistance mutations by ultra-deep sequencing. PLOS ONE 7: e30118. doi:10.1371/journal.pone.0030118. PubMed: 22355307.
6. Campbell MS, Mullins JI, Hughes JP, Celum C, Wong KG, et al. (2011) Viral linkage in HIV-1 seroconverters and their partners in an HIV-1 prevention clinical trial. PLOS ONE 6: e16986. doi:10.1371/journal.pone.0016986. PubMed: 21399681.
7. Redd AD, Collinson-Streng A, Martens C, Ricklefs S, Mullis CE, et al. (2011) Identification of HIV superinfection in seroconcordant couples in Rakai, Uganda, by use of next-generation deep sequencing. J Clin Microbiol 49: 2859-2867. doi:10.1128/JCM.00804-11. PubMed: 21697329.
8. Mulder J, McKinney N, Christopherson C, Sninsky J, Greenfield L, et al. (1994) Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: Application to acute retroviral infection. J Clin Microbiol 32: 292-300. PubMed: 8150937.
9. Palmer S, Wiegand AP, Maldarelli F, Bazmi H, Mican JM, et al. (2003) New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol 41: 4531-4536. doi:10.1128/JCM.41.10.4531-4536.2003. PubMed: 14532178.
10. Rodrigo AG, Goracke PC, Rowhanian K, Mullins JI, (1997) Quantitation of target molecules from polymerase chain reaction-based limiting dilution assays. AIDS Res Hum Retroviruses 13: 737-742. doi:10.1089/aid.1997.13.737. PubMed: 9171217.
11. Liu SL, Rodrigo AG, Shankarappa R, Learn GH, Hsu L, et al. (1996) HIV quasispecies and resampling. Science 273: 415-416. doi:10.1126/science.273.5274.415. PubMed: 8677432.
12. Mallona I, Weiss J, Egea-Cortines M, (2011) pcrEfficiency: a Web tool for PCR amplification efficiency prediction. BMC Bioinformatics 12: 404. doi:10.1186/1471-2105-12-404. PubMed: 22014212.
13. Astrovskaya I, Tork B, Mangul S, Westbrooks K, Mǎndoiu I, et al. (2011) Inferring viral quasispecies spectra from 454 pyrosequencing reads. BMC Bioinformatics 12 (Suppl 6):: S1. doi:10.1186/1471-2105-12-S2-S1. PubMed: 21989211.
14. Macalalad AR, Zody MC, Charlebois P, Lennon NJ, Newman RM, et al. (2012) Highly sensitive and specific detection of rare variants in mixed viral populations from massively parallel sequence data. PLOS Comput Biol 8: e1002417. PubMed: 22438797.
15. Prosperi MC, Salemi M, (2012) QuRe: software for viral quasispecies reconstruction from next-generation sequencing data. Bioinformatics 28: 132-133. doi:10.1093/bioinformatics/btr627. PubMed: 22088846.
16. Quince C, Lanzén A, Curtis TP, Davenport RJ, Hall N, et al. (2009) Accurate determination of microbial diversity from 454 pyrosequencing data. Nat Methods 6: 639-641. doi:10.1038/nmeth.1361. PubMed: 19668203.
17. Zagordi O, Bhattacharya A, Eriksson N, Beerenwinkel N, (2011) ShoRAH: estimating the genetic diversity of a mixed sample from next-generation sequencing data. BMC Bioinformatics 12: 119. doi:10.1186/1471-2105-12-119. PubMed: 21521499.
18. Vandenbroucke I, Van Marck H, Verhasselt P, Thys K, Mostmans W, et al. (2011) Minor variant detection in amplicons using 454 massive parallel pyrosequencing: experiences and considerations for successful applications. BioTechniques 51: 167-177. PubMed: 21906038.
19. Gilles A, Meglécz E, Pech N, Ferreira S, Malausa T, et al. (2011) Accuracy and quality assessment of 454 GS-FLX Titanium pyrosequencing. BMC Genomics 12: 245. doi:10.1186/1471-2164-12-245. PubMed: 21592414.
20. Becker EA, Burns CM, León EJ, Rajabojan S, Friedman R, et al. (2012) Experimental analysis of sources of error in evolutionary studies based on Roche/454 pyrosequencing of viral genomes. Genome Biol Evol 4: 457-465. doi:10.1093/gbe/evs029. PubMed: 22436995.
21. Gianella S, Delport W, Pacold ME, Young JA, Choi JY, et al. (2011) Detection of minority resistance during early HIV-1 infection: natural variation and spurious detection rather than transmission and evolution of multiple viral variants. J Virol 85: 8359-8367. doi:10.1128/JVI.02582-10. PubMed: 21632754.
22. Varghese V, Wang E, Babrzadeh F, Bachmann MH, Shahriar R, et al. (2010) Nucleic acid template and the risk of a PCR-Induced HIV-1 drug resistance mutation. PLOS ONE 5: e10992. doi:10.1371/journal.pone.0010992. PubMed: 20539818.
23. Jabara CB, Jones CD, Roach J, Anderson JA, Swanstrom R, (2011) Accurate sampling and deep sequencing of the HIV-1 protease gene using a Primer ID. Proc Natl Acad Sci U S A 108: 20166-20171. doi:10.1073/pnas.1110064108. PubMed: 22135472.
24. Schmitt MW, Kennedy SR, Salk JJ, Fox EJ, Hiatt JB, et al. (2012) Detection of ultra-rare mutations by next-generation sequencing. Proc Natl Acad Sci U.S.A. PubMed: 22853953.
25. Knierim E, Lucke B, Schwarz JM, Schuelke M, Seelow D, (2011) Systematic comparison of three methods for fragmentation of long-range PCR products for next generation sequencing. PLOS ONE 6: e28240. doi:10.1371/journal.pone.0028240. PubMed: 22140562.
26. Buchbinder SP, Mehrotra DV, Duerr A, Fitzgerald DW, Mogg R, et al. (2008) Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet 372: 1881-1893. doi:10.1016/S0140-6736(08)61591-3. PubMed: 19012954.
27. Rolland M, Tovanabutra S, deCamp AC, Frahm N, Gilbert PB, et al. (2011) Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial. Nat Med 17: 366-371. doi:10.1038/nm.2316. PubMed: 21358627.
28. Adachi A, Gendelman HE, Koenig S, Folks T, Willey R, et al. (1986) Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol 59: 284-291. PubMed: 3016298.
29. Schacker T, Collier AC, Hughes J, Shea T, Corey L, (1996) Clinical and epidemiologic features of primary HIV infection. Ann Intern Med 125: 257-264. doi:10.7326/0003-4819-125-4-199608150-00001. PubMed: 8678387.
30. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ, (1990) Basic local alignment search tool. J Mol Biol 215: 403-410. doi:10.1016/S0022-2836(05)80360-2. PubMed: 2231712.
31. Taswell C, (1981) Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J Immunol 126: 1614-1619. PubMed: 7009746.
32. Deng W, Maust BS, Westfall DH, Chen L, Zhao H, et al. (2013) Indel and Carryforward Correction (ICC): A new analysis approach for processing 454 pyrosequencing data. Bioinformatics (. (2013)) PubMed: 23900188.
33. Iyer S, Bouzek H, Deng W, Larsen BB, Casey E, et al. (2013) Quality score based identification and correction of pyrosequencing errors. PLOS ONE 8(9):: e73015.
34. Roberts JD, Bebenek K, Kunkel TA, (1988) The accuracy of reverse transcriptase from HIV-1. Science 242: 1171-1173. doi:10.1126/science.2460925. PubMed: 2460925.
35. Balduin M, Oette M, Däumer MP, Hoffmann D, Pfister HJ, et al. (2009) Prevalence of minor variants of HIV strains at reverse transcriptase position 103 in therapy-naïve patients and their impact on the virological failure. J Clin Virol 45: 34-38. doi:10.1016/j.jcv.2009.03.002. PubMed: 19375978.
36. Geretti AM, Fox ZV, Booth CL, Smith CJ, Phillips AN, et al. (2009) Low-frequency K103N strengthens the impact of transmitted drug resistance on virologic responses to first-line efavirenz or nevirapine-based highly active antiretroviral therapy. J Acquir Immune Defic Syndr 52: 569-573. doi:10.1097/QAI.0b013e3181ba11e8. PubMed: 19779307.
37. Johnson JA, Li JF, Wei X, Lipscomb J, Irlbeck D, et al. (2008) Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naïve populations and associate with reduced treatment efficacy. PLOS Med 5: e158. doi:10.1371/journal.pmed.0050158. PubMed: 18666824.
38. Metzner KJ, Giulieri SG, Knoepfel SA, Rauch P, Burgisser P, et al. (2009) Minority quasispecies of drug-resistant HIV-1 that lead to early therapy failure in treatment-naive and-adherent patients. Clin Infect Dis 48: 239-247. doi:10.1086/595703. PubMed: 19086910.
39. Paredes R, Lalama CM, Ribaudo HJ, Schackman BR, Shikuma C, et al. (2010) Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failure. J Infect Dis 201: 662-671. PubMed: 20102271.
40. Simen BB, Simons JF, Hullsiek KH, Novak RM, Macarthur RD, et al. (2009) Low-Abundance Drug-Resistant Viral Variants in Chronically HIV-Infected, Antiretroviral Treatment-Naive Patients Significantly Impact Treatment Outcomes. J Infect Dis 199: 693-701. doi:10.1086/596736. PubMed: 19210162.
41. Jakobsen MR, Tolstrup M, Søgaard OS, Jørgensen LB, Gorry PR, et al. (2010) Transmission of HIV-1 drug-resistant variants: prevalence and effect on treatment outcome. Clin Infect Dis 50: 566-573. doi:10.1086/650001. PubMed: 20085464.
42. Metzner KJ, Rauch P, von Wyl V, Leemann C, Grube C, et al. (2010) Efficient suppression of minority drug-resistant HIV type 1 (HIV-1) variants present at primary HIV-1 infection by ritonavir-boosted protease inhibitor-containing antiretroviral therapy. J Infect Dis 201: 1063-1071. doi:10.1086/651136. PubMed: 20196655.
43. Peuchant O, Thiébaut R, Capdepont S, Lavignolle-Aurillac V, Neau D, et al. (2008) Transmission of HIV-1 minority-resistant variants and response to first-line antiretroviral therapy. AIDS 22: 1417-1423. doi:10.1097/QAD.0b013e3283034953. PubMed: 18614864.
44. Stekler JD, Ellis GM, Carlsson J, Eilers B, Holte S, et al. (2011) Prevalence and impact of minority variant drug resistance mutations in primary HIV-1 infection. PLOS ONE 6: e28952. doi:10.1371/journal.pone.0028952. PubMed: 22194957.
45. Bimber BN, Burwitz BJ, O'Connor S, Detmer A, Gostick E, et al. (2009) Ultradeep pyrosequencing detects complex patterns of CD8+ T-lymphocyte escape in simian immunodeficiency virus-infected macaques. J Virol 83: 8247-8253. doi:10.1128/JVI.00897-09. PubMed: 19515775.
46. Bimber BN, Dudley DM, Lauck M, Becker EA, Chin EN, et al. (2010) Whole-genome characterization of human and simian immunodeficiency virus intrahost diversity by ultradeep pyrosequencing. J Virol 84: 12087-12092. doi:10.1128/JVI.01378-10. PubMed: 20844037.
47. Love TM, Thurston SW, Keefer MC, Dewhurst S, Lee HY, (2010) Mathematical modeling of ultradeep sequencing data reveals that acute CD8+ T-lymphocyte responses exert strong selective pressure in simian immunodeficiency virus-infected macaques but still fail to clear founder epitope sequences. J Virol 84: 5802-5814. doi:10.1128/JVI.00117-10. PubMed: 20335256.